Abstract View

Author(s): Khan Ramiz Viquar*1, Vaibhavi Santosh Dhangar2, Nikita Ravindra Pagare3, Koli Punam Suresh4, Pranjal Komalsing Girase5

Email(s): 1khanramiz313@gmail.com

Address:

    Department of pharmaceutics Dadasaheb Rawal Pharmacy College Dondaicha

Published In:   Volume - 5,      Issue - 6,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5602  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Withania somnifera (L.) Dunal, commonly known as Ashwagandha or Indian ginseng, is one of the most important medicinal plants used in traditional Ayurvedic medicine for more than 3000 years. It has historically been employed as a rejuvenating tonic (Rasayana) to enhance vitality, promote longevity, and improve resistance to stress. In recent years, scientific interest in Ashwagandha has increased considerably because of its broad spectrum of pharmacological activities and potential therapeutic applications. Various preclinical and clinical studies have demonstrated that Ashwagandha possesses adaptogenic, antioxidant, anti-inflammatory, antimicrobial, immunomodulatory, neuroprotective, cardio protective, antidiabetic, and reproductive health-promoting properties. These biological activities are mainly attributed to the presence of bioactive constituents such as withanolides, alkaloids, flavonoids, and other phytochemicals. Furthermore, growing evidence suggests its beneficial role in managing stress, anxiety, sleep disorders, cognitive impairment, chronic fatigue, thyroid dysfunction, and enhancement of physical performance. Despite promising outcomes, current evidence remains limited by methodological heterogeneity, variations in dosage regimens, extract standardization, study duration, and relatively small sample sizes. This review aims to provide a comprehensive overview of the Phytochemistry, pharmacological activities, therapeutic potential, and possible mechanisms of action of Withania somnifera, while critically evaluating current scientific evidence and highlighting existing limitations.

Cite this article:
Khan Ramiz Viquar, Vaibhavi Santosh Dhangar, Nikita Ravindra Pagare, Koli Punam Suresh, Pranjal Komalsing Girase. Withania somnifera (Ashwagandha): An Updated Review. IJRPAS, June 2026; 5(6): 20-35.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5602


References not available.

Related Images:



Recent Images



Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds
In-vitro Evaluation of Anti-Urolithiatic Activity of Hydroalcoholic Extract of Centella asiatica Leaves
Quality by Design (Qbd) Based Method Development and Validation of Trelagliptin Succinate byu RP-HPLC.
Cubosomes: Structure, Preparation Methods, Characterization, and Pharmaceutical Applications
Programmable Oral Drug Delivery Systems: Materials, Device Engineering, Stimuli-Responsive Mechanisms, and Clinical Translation
Biomimetic Nanocarrier for Targeted Drug Delivery: An Integrated Review
From Phosphate Wasting to Targeted Therapy: An Updated Review of FGF23-Mediated Hypophosphatemic Rickets
Nanotechnology-Based Drug Delivery Systems for Alzheimer’s Disease: Emerging Strategies for Blood–Brain Barrier Targeting
Explainable AI in Pharmacy: Building Trust in AI-Based Drug Recommendation

Tags